TherapeuticsMD (NASDAQ:TXMD) Stock

TherapeuticsMD

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

I53 Investments Since 2017

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

AULT

TXMD

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

Small Cap

Pre-Market Outlook

Movers

ADTN

AIMD

ALNA

ANTX

APGN

ATXG

AVCO

AVTX

AVYA

BBBY

BIAF

BIVI

BLTE

BRCN

CAMP

CMCM

CRTD

CTMX

CYTK

DRMA

DWAC

ECOM

EHTH

EIGR

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

EURN

FAZE

FRZA

FUTU

FWBI

GEHI

GETY

GROV

GRTX

HIVE

HLVX

HPCO

HYRE

IDAI

ISEE

MGAM

MLTX

MNMD

NEON

NUTX

NUWE

ONVO

PIXY

PROK

PXMD

RGLS

RGTI

SERA

SHPH

SLQT

SPRO

SQFT

TELL

TNGX

WHLR

WING

WTRH

ZETA

ZFOX

ZYME

Gainers


	Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.


Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday

Intraday Update

AMTD

GILD

ILMN

MEGL

POSH

SNAP

TLRY

VRDN


	Magic Empire Global Limited (NASDAQ: MEGL) shares climbed 80.9% to $14.87 on volatility following the company&#39;s IPO earlier this month.


Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday

TherapeuticsMD Inc

Press Releases

TherapeuticsMD Announces Full Year 2023 Financial Results

TherapeuticsMD Announces First Quarter 2024 Financial Results

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Athira Pharma

Aytu BioPharma

Biofrontera

Cingulate

Cocrystal Pharma

China Pharma Holding

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Evoke Pharma

Gelteq

Hoth Therapeutics

Impact BioMedical

Jaguar Health

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Talphera

Traws Pharma

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals

Cantor Fitzgerald

HC Wainwright & Co.

Comments

TherapeuticsMD

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga